Search Results - "Taibi, C"

Hepatitis C diagnosis and treatment in people who use drugs: mind the gap in the linkage to care by Taibi, C, Luzzitelli, I, Visco Comandini, U, Girardi, E, Monacelli, G, Rapisarda, L M, Garbuglia, A R, Minosse, C, Guarrasi, V, Vincenzi, L, Iacomi, F, D'Offizi, G

“…The objective of this study is to identify a simplified rapid screening and linkage-to-care model for HCV among PWUD. The study stems from a collaborative…”
Get more information

Virological and clinical significance of detectable HCV-RNA below limit of quantification at End-of-Treatment in patients treated with direct antiviral agents by Comandini, U.V, Lapa, D, Lionetti, R, Taibi, C, Loiacono, L, Montalbano, M, Capobianchi, M, D’Offizi, G, Garbuglia, A.R

Get full text

Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replication by Cimini, E., Bordoni, V., Sacchi, A., Visco-Comandini, U., Montalbano, M., Taibi, C., Casetti, R., Lalle, E., D’Offizi, G., Capobianchi, M.R., Agrati, C.

“…•The liver was enriched of Vγ9Vδ2 T-cells expressing an effector/activated phenotype, independently from HCV infection.•An enrichment of PD-1+Vγ9Vδ2 T-cells…”
Get full text

Improved virological outcomes and excellent safety profile in genotype 3 HCV-infected cirrhotic patients after an extended 24-weeks course of daclatasvir, sofosbuvir + ribavirin: insights from a real-life multicenter study by Lionetti, R, Lenci, I, Siciliano, M, Pompili, M, Comandini, U.V, Milana, M, Taibi, C, Montalbano, M, Garbuglia, A.R, Begini, P, Imperatrice, B, Angelico, M, D’Offizi, G

Get full text

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro‐resected patient by Taibi, C., Tempestilli, M., D'Avolio, A., Garbuglia, A. R., De Nicolò, A., Montalbano, M., D'Offizi, G.

“…Summary What is known and objective The second‐generation direct‐acting antivirals represented the first major turning point for the eradication of HCV…”
Get full text

Impact of DAA therapy on health-related quality of life in liver transplanted patients. Is there a role for ribavirin? by Lionetti, R, Palummieri, A, Taibi, C, Medici, E, Montalbano, M, Visco Comandini, U, Loiacono, L, Puro, V, Ettorre, G.M, Giulianelli, M, D’Offizi, G

Get full text

SAT-287 - Virological and clinical significance of detectable HCV-RNA below limit of quantification at End-of-Treatment in patients treated with direct antiviral agents by Comandini, U.V., Lapa, D., Lionetti, R., Taibi, C., Loiacono, L., Montalbano, M., Capobianchi, M., D’Offizi, G., Garbuglia, A.R.

Get full text

Overall survival and incidence of liver-related events in a cohort of cirrhotic patients treated with direct antiviral agents: results from a multicenter study by Masetti, C., Marignani, M., Lionetti, R., Gentilucci, U. Vespasiani, Santopaolo, F., Milana, M., Begini, P., Taibi, C., Galati, G., Comandini, U. Visco, D’Offizi, G., Angelico, M.

Get full text

Infection‐related and ‐unrelated malignancies, HIV and the aging population by Borges, ÁH, Ledergerber, B, Domingo, P, Knysz, B, Karpov, I, Kirk, O, Lundgren, J, Clumeck, N., Vandekerckhove, L., Machala, L., Kronborg, G., Larsen, M., Gerstoft, J., Katzenstein, T., Skinhøj, P., Pedersen, C., Dragsted, U. B., Zilmer, K., Girard, P‐M., Vanhems, P., Pradier, C., Neau, D., Schmidt, R., Lunzen, J., Stellbrink, H. J., Bickel, M., Fätkenheuer, G., Kosmidis, J., Gargalianos, P., Perdios, J., Gottfredsson, M., Burke, M., Pollack, S., Hassoun, G., Haouzi, M., Esposito, R., Arici, C., Pristera, R., Mazzotta, F., Montesarchio, E., Gargiulo, M., D'Offizi, G., Taibi, C., Antinori, A., Lazzarin, A., Ridolfo, A., Chaplinskas, S., Reiss, P., Ormaasen, V., Boron‐Kaczmarska, A., Pynka, M., Parczewski, M., Mularska, E., Jablonowska, E., Wojcik, K., Doroana, M., Caldeira, L., Maltez, F., Duiculescu, D., Rakhmanova, A., Buzunova, S., Jevtovic, D., Mokráš, M., Staneková, D., Rodriguez, J. M., Bravo, I., Gatell, J. M., Medrano, J., Flamholc, L., Weber, R., Francioli, P., Cavassini, M., Boffi, E., Battegay, M., Elzi, L., Kravchenko, E., Frolov, V., Kutsyna, G., Servitskiy, S., Kuznetsova, A., Kyselyova, G., Simons, E., Orkin, C., Fisher, M., Horban, A., Pedersen, C., Rakhmanova, A., Phillips, A., Cozzi‐Lepri, A., Grint, D., Schultze, A., Raben, D., Kjær, J., Fischer, A. H., Grarup, J., Thiebaut, R., Burger, D., Paredes, R., Kjær, J., Peters, L.

“…Objectives HIV‐positive people have increased risk of infection‐related malignancies (IRMs) and infection‐unrelated malignancies (IURMs). The aim of the study…”
Get full text

SAT-257 - Improved virological outcomes and excellent safety profile in genotype 3 HCV-infected cirrhotic patients after an extended 24-weeks course of daclatasvir, sofosbuvir + ribavirin: insights from a real-life multicenter study by Lionetti, R., Lenci, I., Siciliano, M., Pompili, M., Comandini, U.V., Milana, M., Taibi, C., Montalbano, M., Garbuglia, A.R., Begini, P., Imperatrice, B., Angelico, M., D’Offizi, G.

Get full text

The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19 by Biliotti, E., Piselli, P., Visco Comandini, U., Lionetti, R., Taibi, C., Vincenzi, L., Moghazi, S. Al, Antinori, A., Caraffa, E., Cimaglia, C., Marchioni, L., Mariano, A., Mastrorosa, I., Mosti, S., Navarra, A., Nicastri, E., Palmieri, F., Girardi, E., D'Offizi, G., Study Group, ReCOVeRI

Get full text

FRI-379 - Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis by Masetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F., Teti, E., Dell’unto, C., Francioso, S., Brega, A., Montalbano, M., Comandini, U.V., Taibi, C., Galati, G., Gentilucci, U.V., Picardi, A., Andreoni, M., Pompili, M., Pellicelli, A., D’offizi, G., Gasbarrini, A., De Santis, A., Mario, A.

Get full text

Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis by Masetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F., Teti, E., Dell’unto, C., Francioso, S., Brega, A., Montalbano, M., Comandini, U.V., Taibi, C., Galati, G., Gentilucci, U.V., Picardi, A., Andreoni, M., Pompili, M., Pellicelli, A., D’offizi, G., Gasbarrini, A., De Santis, A., Mario, A.

Get full text

Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis by Masetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F.R., Teti, E., Dell’Unto, C., Francioso, S., Brega, A., Montalbano, M., Visco-Comandini, U., Taibi, C., Galati, G., Gentilucci, U. Vespasiani, Picardi, A., Andreoni, M., Pompili, M., Pellicelli, A.M., D’Offizi, G., Gasbarrini, A., De Santis, A., Angelico, M.

Get full text

Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents by Minosse, Claudia, Selleri, Marina, Giombini, Emanuela, Bartolini, Barbara, Capobianchi, Maria Rosaria, Cerilli, Stefano, Loiacono, Laura, Taibi, Chiara, D'Offizi, Gianpiero, McPhee, Fiona, Garbuglia, AnnaRosa

“…The efficacy of direct-acting antivirals (DAAs) depends on the hepatitis C virus (HCV) genotype 4 (GT4) subtype which are used in the treatment of HCV. We…”
Get full text

In HIV/HCV Coinfected Patients Dendritic Cell Activation State Is Not Associated With IL28B Genotype by Sacchi, Alessandra, Lapa, Daniele, Garbuglia, Anna Rosa, Taibi, Chiara, Tumino, Nicola, D'Offizi, Gianpiero, Martini, Federico

Get full text

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study by Podlekareva, D, Grint, D, Karpov, I, Rakmanova, A, Mansinho, K, Chentsova, N, Zeltina, I, Losso, M, Parczewski, M, Lundgren, JD, Mocroft, A, Kirk, O

“…Objectives The long‐term side effects of stavudine (d4T) led to recommendations in 2009 to phase out use of this drug. We aimed to describe temporal patterns…”
Get full text

A 76-year-old woman with pre-renal azotaemia and Morgagni's hernia by Spoto, Silvia, Fazzina, Sara, Taibi, Chiara

Get full text

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient by Taibi, C, Tempestilli, M, D'Avolio, A, Garbuglia, A R, De Nicolò, A, Montalbano, M, D'Offizi, G

“…WHAT IS KNOWN AND OBJECTIVEThe second-generation direct-acting antivirals represented the first major turning point for the eradication of HCV infection in…”
Get full text